Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$601M |
| 2 |
Moderna
MRNA
|
+$557M |
| 3 |
Analog Devices
ADI
|
+$448M |
| 4 |
FlexShares Global Upstream Natural Resources Index Fund
GUNR
|
+$445M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$406M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$652M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$512M |
| 3 |
TSMC
TSM
|
+$378M |
| 4 |
JPMorgan Chase
JPM
|
+$318M |
| 5 |
MXIM
Maxim Integrated Products
MXIM
|
+$305M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.12% |
| 2 | Financials | 12.68% |
| 3 | Healthcare | 12.53% |
| 4 | Consumer Discretionary | 11.26% |
| 5 | Communication Services | 9.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
Cars.com
CARS
$674M
| $9.64M | ﹤0.01% |
762,202
+8,224
| +1% | +$104K |
|
2302
Nurix Therapeutics
NRIX
$2.41B
| $9.62M | ﹤0.01% |
321,006
+24,116
| +8% | +$744K |
|
|
MGP
2303
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
| $9.62M | ﹤0.01% |
251,095
+8,433
| +3% | +$330K |
|
2304
Pulmonx
LUNG
$78.6M
| $9.62M | ﹤0.01% |
267,306
+37,777
| +16% | +$1.49M |
|
|
VXRT
2305
DELISTED
Vaxart
VXRT
| $9.6M | ﹤0.01% |
1,207,900
-22,445
| -2% | -$185K |
|
2306
Qfin Holdings
QFIN
$1.69B
| $9.58M | ﹤0.01% |
471,596
+106,838
| +29% | +$2.52M |
|
2307
Aspen Aerogels
ASPN
$390M
| $9.56M | ﹤0.01% |
207,812
-17,178
| -8% | -$681K |
|
2308
Omeros
OMER
$889M
| $9.54M | ﹤0.01% |
691,749
-2,027
| -0.3% | -$30.3K |
|
|
UHT
2309
Universal Health Realty Income Trust
UHT
$600M
| $9.52M | ﹤0.01% |
172,298
-88,264
| -34% | -$5.2M |
|
2310
Vaxcyte
PCVX
$7.82B
| $9.52M | ﹤0.01% |
375,107
+9,455
| +3% | +$229K |
|
|
PETQ
2311
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $9.51M | ﹤0.01% |
380,763
-13,774
| -3% | -$415K |
|
|
FRG
2312
DELISTED
Franchise Group, Inc.
FRG
| $9.5M | ﹤0.01% |
268,276
-7,085
| -3% | -$247K |
|
2313
Transmedics
TMDX
$2.86B
| $9.5M | ﹤0.01% |
287,074
-10,403
| -3% | -$318K |
|
|
NFBK
2314
DELISTED
Northfield Bancorp
NFBK
| $9.49M | ﹤0.01% |
553,234
-10,900
| -2% | -$179K |
|
|
HNGR
2315
DELISTED
Hanger Inc.
HNGR
| $9.48M | ﹤0.01% |
431,799
-14,930
| -3% | -$346K |
|
2316
Krystal Biotech
KRYS
$8.97B
| $9.47M | ﹤0.01% |
181,434
-7,121
| -4% | -$422K |
|
2317
NRC Health Common Stock
NRC
$447M
| $9.46M | ﹤0.01% |
224,280
+2,512
| +1% | +$126K |
|
2318
Movado Group
MOV
$856M
| $9.45M | ﹤0.01% |
300,192
-9,414
| -3% | -$301K |
|
2319
Nomura Holdings
NMR
$27.9B
| $9.45M | ﹤0.01% |
1,912,935
-1,109,208
| -37% | -$5.54M |
|
|
BMTC
2320
DELISTED
Bryn Mawr Bank Corp
BMTC
| $9.44M | ﹤0.01% |
205,439
-9,351
| -4% | -$378K |
|
2321
1-800-Flowers.com
FLWS
$265M
| $9.43M | ﹤0.01% |
308,960
-9,362
| -3% | -$296K |
|
|
DQ
2322
Daqo New Energy
DQ
$907M
| $9.43M | ﹤0.01% |
165,355
-51,273
| -24% | -$3.07M |
|
|
GES
2323
DELISTED
Guess Inc
GES
| $9.42M | ﹤0.01% |
448,366
-14,130
| -3% | -$323K |
|
2324
DNOW Inc
DNOW
$2.6B
| $9.39M | ﹤0.01% |
1,227,204
-41,692
| -3% | -$341K |
|
|
VNE
2325
DELISTED
Veoneer, Inc.
VNE
| $9.38M | ﹤0.01% |
275,540
+31,365
| +13% | +$997K |
|
Similar funds
Northern Trust's Q3 2021 Portfolio in Review
As of Q3 2021, Northern Trust held 4,828 positions worth $565B, down 0.48% from $568B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Northern Trust's Q3 2021 filing shows 242 new, 1,428 increased, 2,705 reduced and 176 closed positions. Its largest new stake was Dimensional International Value ETF: 4,656,805 shares worth $152M. The largest sale was Alphabet (Google) Class C, an estimated $652M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- Northern Trust's largest Q3 2021 buy was Dimensional International Value ETF: 4,656,805 shares worth $152M.
- Northern Trust added most to Johnson & Johnson in Q3 2021, an estimated $601M increase.
- Northern Trust's biggest Q3 2021 reduction was Alphabet (Google) Class C, cutting an estimated $652M.
- Northern Trust fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $512M.
- Northern Trust's ten largest holdings make up 22% of its $565B portfolio in Q3 2021.
- Northern Trust opened 242 new positions and closed 176 in Q3 2021.
- Northern Trust's portfolio value fell 0.48% quarter-over-quarter to $565B.
Based on Northern Trust's 13F filing for Q3 2021, filed 15 Nov 2021.